BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35967860)

  • 1. Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.
    Tang H; Zhou H; Zhang R
    Front Cell Infect Microbiol; 2022; 12():958210. PubMed ID: 35967860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubo-ovarian abscess in virginal adolescent females: a case report and review of the literature.
    Goodwin K; Fleming N; Dumont T
    J Pediatr Adolesc Gynecol; 2013 Aug; 26(4):e99-102. PubMed ID: 23566794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M; Baysal B
    Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of persistent tubo-ovarian abscess in Nairobi, Kenya.
    Cohen CR; Gravelle L; Symekher S; Waiyaki P; Stamm WE; Kiehlbauch JA
    Infect Dis Obstet Gynecol; 2003; 11(1):45-51. PubMed ID: 12839632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abiotrophia/Granulicatella tubo-ovarian abscess in an adolescent virginal female.
    Gensheimer WG; Reddy SY; Mulconry M; Greves C
    J Pediatr Adolesc Gynecol; 2010 Feb; 23(1):e9-12. PubMed ID: 19682931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for antibiotic therapy failure in women with tubo-ovarian abscess: A systematic review and meta-analysis.
    Kinay T; Akay A; Aksoy M; Celik Balkan F; Engin Ustun Y
    J Obstet Gynaecol Res; 2024 Mar; 50(3):298-312. PubMed ID: 38184888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
    Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
    Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess.
    Klug TE
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.
    Wang J; Zhang H; Yan J; Zhang T
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):861-870. PubMed ID: 32102584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complicated Clinical Course and Poor Reproductive Outcomes of Women with Tubo-Ovarian Abscess after Fertility Treatments.
    Fouks Y; Cohen Y; Tulandi T; Meiri A; Levin I; Almog B; Cohen A
    J Minim Invasive Gynecol; 2019 Jan; 26(1):162-168. PubMed ID: 29890350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
    Tally FP; Cuchural GJ; Malamy MH
    Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can antibiotic treatment failure in tubo-ovarian abscess be predictable?
    Akselim B; Karaşin SS; Demirci A; Üstünyurt E
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():253-257. PubMed ID: 33482459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consequences of suppression of anaerobic bacteria.
    Fry DE; Schermer CR
    Surg Infect (Larchmt); 2000; 1(1):49-56. PubMed ID: 12594909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery.
    Karaca K; Ozkaya E; Kurek Eken M; Uygun I; Kopuk SY; Alpay M
    J Obstet Gynaecol; 2018 Aug; 38(6):818-821. PubMed ID: 29523046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment?
    Halperin R; Levinson O; Yaron M; Bukovsky I; Schneider D
    Gynecol Obstet Invest; 2003; 55(4):211-5. PubMed ID: 12904694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubo-ovarian abscess caused by
    Cox K; Crowley M; Fryer K
    Case Rep Womens Health; 2022 Oct; 36():e00444. PubMed ID: 36039161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.